« FDA approves first drug to treat a rare bone marrow | Main | FDA Approvals - FDA touts uptick in new drug approvalsThe Food and Drug »

FDA approves Xarelto to prevent stroke in people with common


FDA approves Xarelto to prevent stroke in people with common type of abnormal heart rhythm
The U.S. Food and Drug Administration today approved the anti-clotting drug Xarelto (rivaroxaban) to reduce the risk of stroke in people who have abnormal heart rhythm (non-valvular atrial fibrillation).
 

©2006 FDA-News.com. All rights reserved.